Document Classification

Section Type: RESULTS

Text: The results indicate that TP 37. 5 / 325 mg was superior to CP 30/500 mg in terms of higher analgesic efficacy (VSR at 24 hours : CP 30/500, 2. 52 + / - 0. 86 vs. TP 37. 5 / 325, 1. 40 + / - 0. 76 ; p < 0. 001), less patients reporting adverse events (CP 30/500 : 62 % vs. TP 37. 5 / 325 : 36 % ; p < 0. 01), less patients requiring rescue medications (CP 30/500 : 18. 2 % vs. TP 37. 5 / 325 : 5. 5 % ; p < 0. 01), and more favorable judgment (scored '' excellent '' by 16 % and 54. 5 % of CP 30/500 or TP 37. 5 / 325-treated patients, respectively ; p < 0. 001).